eCite Digital Repository
Three fundamental features a Health Technology Assessment Organisation should possess and how the Pharmaceutical Benefits Advisory Committee in Australia performs against each criterion
Citation
Veal, FC, Three fundamental features a Health Technology Assessment Organisation should possess and how the Pharmaceutical Benefits Advisory Committee in Australia performs against each criterion (2010) [Masters Coursework]
 | PDF Pending copyright assessment - Request a copy 559Kb |
Abstract
It has been projected that pharmaceutical expenditure shall be the fastest growing and largest component of the Australian health care budget over the next 50 years. Thus, the need for the Pharmaceutical Benefits Advisory Committee (PBAC), the Australian Pharmaceutical Health Technology Assessment Organisation (HTAO) to perform to its highest capability is paramount for the sustainability of public subsidisation of pharmaceuticals in Australia. The aim of this paper is to evaluate how well the PBAC, performs against three criteria, considered essential to maximise performance: independence, transparency and stakeholder inclusion, which will be evaluated by undertaking a review of the literature related to the PBAC. Recommendations regarding ways to improve the PBAC's performance will also be made.
Item Details
| Item Type: | Masters Coursework |
|---|---|
| Keywords: | Australia, pharmacy, health technology assessment |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Pharmacology and pharmaceutical sciences |
| Research Field: | Clinical pharmacy and pharmacy practice |
| Objective Division: | Health |
| Objective Group: | Evaluation of health and support services |
| Objective Field: | Health policy evaluation |
| UTAS Author: | Veal, FC (Dr Felicity Veal) |
| ID Code: | 150576 |
| Year Published: | 2010 |
| Deposited By: | Pharmacy |
| Deposited On: | 2022-06-21 |
| Last Modified: | 2022-07-05 |
| Downloads: | 0 |
Repository Staff Only: item control page